These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ, Shaheen FA. Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [Abstract] [Full Text] [Related]
3. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease. Panawong W, Chaiyakum A, Pongskul C. J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501 [Abstract] [Full Text] [Related]
4. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Thanamayooran S, Rose C, Hirsch DJ. Nephrol Dial Transplant; 2005 Nov; 20(11):2385-93. PubMed ID: 16046506 [Abstract] [Full Text] [Related]
5. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt. Ibrahim S. Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297 [Abstract] [Full Text] [Related]
8. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, Anderson CS, Chalmers JP, Cass A. Nephrol Dial Transplant; 2012 Apr; 27(4):1396-402. PubMed ID: 22053091 [Abstract] [Full Text] [Related]
9. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients. Souqiyyeh MZ, Shaheen FA. Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943 [Abstract] [Full Text] [Related]
10. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA. Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885 [Abstract] [Full Text] [Related]
11. Executing change in the management of chronic kidney disease: perspectives on guidelines and practice. Levin A, Stevens LA. Med Clin North Am; 2005 May; 89(3):701-9. PubMed ID: 15755474 [Abstract] [Full Text] [Related]
15. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Martin KJ, González EA. Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848 [Abstract] [Full Text] [Related]
17. Clinical practice guidelines: barriers to durability after effective early implementation. Brand C, Landgren F, Hutchinson A, Jones C, Macgregor L, Campbell D. Intern Med J; 2005 Mar; 35(3):162-9. PubMed ID: 15737136 [Abstract] [Full Text] [Related]
18. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E. Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962 [Abstract] [Full Text] [Related]
19. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications. Uribarri J, National Kidney Foundation. Semin Dial; 2004 Apr; 17(5):349-50. PubMed ID: 15461740 [Abstract] [Full Text] [Related]